COMPANY PROFILE
Innovative Molecules GmbH
GmbH (Limited Liability Company)MünchenResearch and experimental development on biotechnology
FOUNDED
2016
9+ years active
TRADE REGISTER
HRB 267074
München
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Medium-sized enterprise
Key questions answered
What does the company do?
Forschung und Entwicklung, Zulassung, Herstellung sowie der Vertrieb pharmazeutischer Erzeugnisse.
Who leads it?
Thomas Hoffmann, Gerald Kleymann
How large is it?
Medium-sized enterprise
How stable is it?
Stability assessment in Plus profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Medium
Industry (WZ2008) (3)
- M72.11Research and experimental development on biotechnology
- C21.10Manufacture of basic pharmaceutical products
- C32.50Manufacture of medical and dental instruments and supplies
Business purpose
Forschung und Entwicklung, Zulassung, Herstellung sowie der Vertrieb pharmazeutischer Erzeugnisse.
Legal essentials
- Register entry
- HRB 267074 (München)
- Legal form
- GmbH (Limited Liability Company)
- Founded
- 20 Sept 2016
- Share capital
- €116,000
- VAT ID
- —
- LEI
- —
- Representation rules
- Ist nur ein Geschäftsführer bestellt, so vertritt er die Gesellschaft allein. Sind mehrere Geschäftsführer bestellt, so wird die Gesellschaft durch zwei Geschäftsführer oder durch einen Geschäftsführer gemeinsam mit einem Prokuristen vertreten.
Order shareholder list
The statutory shareholder list (§ 40 GmbHG) straight from the official register portal — who holds which shares.
Available once you sign in
Annual statements
No public annual statements on file.
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are shown in the Plus profile only.
- Continuity1Available in Plus profile
- Financials2Available in Plus profile
- Management3Available in Plus profile
- Legal status4Available in Plus profile
Directors & officers
Managing directors
Thomas Hoffmann
Managing Director
Gerald Kleymann
Managing Director
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Commercial register history
No events on file.
Companies with a similar profile
Delta 9 Cannabis Research GmbH
Neuss
Blueprint Medicines (Germany) GmbH
München
meliodays medical GmbH
Leipzig
Valerius Biopharma GmbH
Weil am Rhein
Pharmact GmbH
Mannheim
denovoMATRIX GmbH
Dresden
Ariceum Therapeutics GmbH
Berlin
Odyssey Therapeutics GmbH
Frankfurt am Main
Evumed Germany GmbH
Berlin
MDTB Cell Manufacturing GmbH
Dresden
Location neighbours
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
What the Plus profile adds
The same page, fully populated — plus the research services locked here.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- Contact search: names, roles, phone, email, LinkedIn
- Shareholder list from the official register portal
- News research covering the last six months
- The full commercial register history